Run your numbers in 30 seconds.

See the obesity-related medical cost already in your plan, and what brand-name GLP-1s at list price would add.

Employees on your plan 150Members who enroll 10%

Medication

Employees likely living with obesity¹0

Obesity’s extra medical cost in your plan, per year²$0

Those members on brand-name GLP-1s at list price, per year³$0

Members who enroll is your assumption. Uptake depends on coverage level and communication; start conservative.
Brand-name cost uses published list prices³⁴ for the members you expect to enroll. Your PBM’s net price after rebates may be lower.
Upgrades pricing is quoted for your company, with no service fee.
Obesity’s extra medical cost multiplies your headcount by adult obesity prevalence¹ and the CDC-cited annual excess medical cost per adult with obesity². It shows the exposure already in your plan, not a promised saving.
Estimates are illustrative and not a guarantee of savings or outcomes.

Pitch it internally

Build a one-pager
with your logo on it.

Add your logo and headcount, choose how you’d cover it, and download a two-page PDF for your CFO, HR team or broker. Every figure is sourced.

40.3% of U.S. adults had obesity, August 2021 to August 2023. CDC, National Center for Health Statistics, Data Brief No. 508 (2024)
$1,861 higher annual medical costs per adult with obesity than at a healthy weight (2019 dollars); cited by CDC. Ward ZJ et al., PLoS ONE 2021;16(3):e0247307
$1,349 list price per monthly package of Wegovy (semaglutide), 2026. Novo Nordisk, NovoCare pricing
$1,086 top of the published list price range per fill for Zepbound (tirzepatide) pens, 2026. Eli Lilly, Zepbound pricing information
9.5% projected increase in U.S. employer health care costs for 2027, to above $19,000 per employee. Aon, August 2026
$26,993 average annual premium for employer family coverage in 2025, up 6%. KFF 2025 Employer Health Benefits Survey
3 days more missed work per year for workers with obesity than workers at a healthy weight. CDC, Consequences of Obesity (citing Cawley et al., JOEM 2021)
58% of U.S. adults with obesity have high blood pressure. CDC, Adult Obesity Facts
36% of employers cover GLP-1s for weight loss, up from 26% in 2023. International Foundation of Employee Benefit Plans, GLP-1 Drugs Survey (2026)
1 in 12 patients still on a GLP-1 for obesity at three years in a large commercial claims analysis. Prime Therapeutics (2025)
7 points slower medical cost growth at 18 months for GLP-1 weight-loss users who stayed on therapy consistently, versus similar non-users. Aon (January 2026)

Thirty minutes, your broker welcome in the room. Bring your current pharmacy numbers and we’ll show you exactly where the program fits.